About Bloomage Biotechnology
Bloomage Biotechnology is a publicly listed company based in Jinan (China) founded in 1998. Manufacturer of hyaluronic acid pharmaceutical products. It operates in the Chemicals & Materials and Healthcare sectors. The company has 4,440 employees. Bloomage Biotechnology has completed 1 acquisition, including Beijing Yierkang Bioengineering. Its chief executive, as recorded, is Zhao Yan. Its focus areas include Chemicals and Materials, Diversified Chemicals, Speciality Chemicals and Biopharma Outsourcing. Its competitors include Qingdao Kangyuan Pharmaceutica, Minxiang Biomedical and Viablife.
Company details
Founded in 1998 in Jinan, China, operations are focused on the biotechnology sector, where hyaluronic acid and pharmaceutical products are produced. Additional manufacturing includes cosmetic and food-grade products, as well as bioactive materials. Technical support is provided to clients. The company serves global markets through its domain, bloomagebioactive.com, with leadership held by CEOs Zhao Yan and Xue Kun Jin.
- Headquarters Jinan, China
- Employees 4,440
- Stage Public
- SectorsChemicals & MaterialsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website bloomagebioactive.com
- Social LinkedIn Instagram YouTube
- Legal Name Bloomage Biotechnology Corp. Ltd. Class A
- Annual Revenue$595.63 M (USD)-21.37as on Dec 31, 2025
- Net Profit$41.72 M (USD)67.59as on Dec 31, 2025
- EBITDA$89.61 M (USD)13.23as on Dec 31, 2025
- Employee Count4,440
- Investments & Acquisitions
People of Bloomage Biotechnology
2 people are tracked at Bloomage Biotechnology (2 in leadership); the tracked headcount is 4,440.
| Name | Role | Group |
|---|---|---|
Zhao Yan | CEO | Leadership |
Xue Kun Jin | CEO | Leadership |
Complete people profiles for Bloomage Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Bloomage Biotechnology
Bloomage Biotechnology is a publicly listed company on the SSE with ticker symbol 688363 in China, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Nov 2019
- Listed onSSE: 688363
- Listed entityBloomage Biotechnology Corp. Ltd. Class A
- Exchange sectorProcess industries
- ISINCNE100003NL9
- Share price33.46 CNY (-1.67% on the day) · 2026-10-14
- Market capitalisation16,278,683,184.00 CNY
- Price to earnings71.4
- EPS (diluted, trailing year)0.47 CNY
- Dividend yield0.56%
- Volume (last session)1,982,853
Financials of Bloomage Biotechnology
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 4.17B CNY | 292.1M CNY | 627.3M CNY |
| 2024 | 5.31B CNY | 174.3M CNY | 554.0M CNY |
| 2023 | 6.01B CNY | 592.6M CNY | 860.4M CNY |
| 2022 | 6.28B CNY | 970.9M CNY | 1.18B CNY |
| 2021 | 4.90B CNY | 782.3M CNY | 905.2M CNY |
Detailed financial statements for Bloomage Biotechnology
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bloomage Biotechnology
Bloomage Biotechnology has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Beijing Yierkang Bioengineering.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Manufacturer of artificial bone and collagen sponge | bjyek.com | Liaoyuan, China | 1997 | Apr 2022 | •••• |
Complete acquisition details for Bloomage Biotechnology
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Bloomage Biotechnology
3 dated milestones of Bloomage Biotechnology across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Bloomage Biotechnology is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Beijing Yierkang Bioengineering.
Competitors of Bloomage Biotechnology
Bloomage Biotechnology has 3 listed competitors in our database. They include Qingdao Kangyuan Pharmaceutica, Minxiang Biomedical and Viablife.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kangyuan.com.cn | 2001 | Qingdao, China | Operates as a CDMO specializing in hyaluronidase manufacturing. | |||
| mxpharm.com | 2005 | Tianjin, China | CDMO focused on manufacturer of API drugs | |||
| viablife.com | 2015 | Hangzhou, China | APIs are produced by Viablife as a CDMO in pharmaceuticals. |
Detailed competitors of Bloomage Biotechnology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bloomage Biotechnology
The website of Bloomage Biotechnology (bloomagebioactive.com) receives about 5.6K visits a month and ranks #3,706,679 among all websites worldwide, #4,756 in Biotechnology and Pharmaceuticals.
- Monthly visits5.6K
▲ 27.8% vs previous month
- Unique visitors1.8K
per month
- Global rank#3,706,679
among all websites
- Category rank#4,756
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit2.4
- Average visit1 min 39 sec
- DevicesDesktop 34% · Mobile 66%
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bloomage Biotechnology
Complete news archive for Bloomage Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bloomage Biotechnology
Bloomage Biotechnology was founded in 1998.
Bloomage Biotechnology is headquartered in Jinan, China. It is registered at Jinan, Shandong, China.
Zhao Yan is the CEO of Bloomage Biotechnology, as recorded in our data.
Bloomage Biotechnology has 4,440 employees.
Annual revenue of Bloomage Biotechnology is $595.63M as on Dec 31, 2025.
Founded in 1998 in Jinan, China, operations are focused on the biotechnology sector, where hyaluronic acid and pharmaceutical products are produced. Additional manufacturing includes cosmetic and food-grade products, as well as bioactive materials. Technical support is provided to clients. The company serves global markets through its domain, bloomagebioactive.com, with leadership held by CEOs Zhao Yan and Xue Kun Jin.
Bloomage Biotechnology's top competitors include Minxiang Biomedical, Viablife and Qingdao Kangyuan Pharmaceutica.
Yes, Bloomage Biotechnology is publicly traded on SSE under the ticker symbol 688363.
Bloomage Biotechnology has made 1 acquisition, including Beijing Yierkang Bioengineering.